Your new experience awaits. Try the new design now and help us make it even better

SYSTEMATIC REVIEW article

Front. Neurol.

Sec. Dementia and Neurodegenerative Diseases

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1607945

Efficacy and safety of traditional Chinese medicine and Western medicine in Alzheimer's disease: a systematic review and meta-analysis

Provisionally accepted
Qi  WangQi Wang1De-Long  WangDe-Long Wang2Xiu-Chu  ZhangXiu-Chu Zhang1Xin-Yu  JiangXin-Yu Jiang1Huan-Ning  JiangHuan-Ning Jiang1Xue-Ying  YangXue-Ying Yang3Te  ZhangTe Zhang3Yu-Ying  LvYu-Ying Lv4Quan  LiQuan Li1*
  • 1Heilongjiang University of Chinese Medicine, Harbin, China
  • 2Second Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, China
  • 3The First Harbin Psychiatric Hospital, Harbin, Jilin Province, China
  • 4Harbin Hospital of Traditional Chinese Medicine, Harbin, Jilin Province, China

The final, formatted version of the article will be published soon.

Objective: This study aimed to compare the efficacy and safety of traditional Chinese medicine (TCM) compounds with single Western medicines in treating Alzheimer's disease (AD) through a systematic review and meta-analysis. Methods: In this study, we searched for randomised controlled trials on the treatment of AD with TCM compounds published before March 2025 in Chinese and English databases (PubMed, Embase, Cochrane, China National Knowledge Infrastructure, VIP and Wanfang) and conducted a meta-analysis using Stata15.0 software. Results: A total of 23 studies were included, involving 2,035 participants (1,173 in the experimental group and 862 in the control group). Traditional Chinese herbal compounds showed good clinical efficacy and maintenance effects in the treatment of AD. The effective rate of TCM compounds in treating AD was higher than that of Western medicine (relative risk ratio = 1.19, 95% CI: 1.04–1.37, p = 0.009). In terms of the Alzheimer's Disease Assessment Scale-Cognitive and Hierarchic Dementia Scale-Revised scores, TCM compounds were superior to Western medicine (standardised mean difference = −0.22, 95% CI: −0.40–−0.05). There were no significant differences between the two groups in the Mini-Mental State Examination or Activities of Daily Living scores. Additionally, there were no significant differences in adverse reactions between the TCM compounds and Western medicine groups. Conclusion: Current research indicates that TCM compounds could be a promising therapeutic option for AD, demonstrating encouraging results in terms of efficacy and safety, particularly regarding certain cognitive functions.

Keywords: Alzheimer's disease, Traditional Chinese Medicine, Meta-analysis, Randomised controlled trial, Treatment

Received: 08 Apr 2025; Accepted: 05 Aug 2025.

Copyright: © 2025 Wang, Wang, Zhang, Jiang, Jiang, Yang, Zhang, Lv and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Quan Li, Heilongjiang University of Chinese Medicine, Harbin, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.